Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 90,903 | 56,186 | 10,423 | 11,947 | 67,072 |
| Marketable Securities | 1,501 | 63,127 | 120,000 | 113,841 | 98,983 |
| Receivables | 7,522 | 1,337 | 1,995 | 1,699 | 3,287 |
| Other current assets | 1,468 | 3,531 | 3,111 | 3,181 | 2,561 |
| TOTAL | $101,394 | $124,181 | $135,529 | $130,668 | $171,903 |
| Non-Current Assets | |||||
| PPE Net | 6,560 | 11,071 | 13,511 | 11,387 | 4,156 |
| Investments And Advances | 3,792 | 22,061 | 39,947 | 23,312 | 7,406 |
| Other Non-Current Assets | 1,867 | 520 | 552 | 544 | 538 |
| TOTAL | $12,219 | $33,652 | $54,010 | $35,243 | $12,100 |
| Total Assets | $113,613 | $157,833 | $189,539 | $165,911 | $184,003 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,836 | 6,496 | 14,765 | 11,852 | 10,238 |
| Other current liabilities | 170 | 57 | 57 | N/A | 984 |
| TOTAL | $6,006 | $38,198 | $32,550 | $38,841 | $34,802 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 31,645 | 17,728 | 26,989 | 23,580 |
| Other Non-Current Liabilities | 0 | 266 | 359 | 123 | 49 |
| TOTAL | $N/A | $266 | $9,490 | $16,224 | $36,469 |
| Total Liabilities | $6,006 | $38,464 | $42,040 | $55,065 | $71,271 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,230 | 30,782 | 29,847 | 26,444 | 25,451 |
| Common Shares | 42 | 40 | 39 | 34 | 33 |
| Retained earnings | -329,330 | -298,718 | -254,046 | -210,358 | -188,740 |
| Other shareholders' equity | -48 | -1,038 | 6 | -145 | -4,646 |
| TOTAL | $107,607 | $119,369 | $147,499 | $110,846 | $112,732 |
| Total Liabilities And Equity | $113,613 | $157,833 | $189,539 | $165,911 | $184,003 |